首页> 外文期刊>Theriogenology >Postactivation treatment with nocodazole maintains normal nuclear ploidy of cloned pig embryos by increasing nuclear retention and formation of single pronucleus
【24h】

Postactivation treatment with nocodazole maintains normal nuclear ploidy of cloned pig embryos by increasing nuclear retention and formation of single pronucleus

机译:诺考达唑的活化后处理通过增加核保留和单个前核的形成来维持克隆的猪胚胎的正常核倍性。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to investigate the effects of postactivation treatment with nocodazole on morphologic changes of donor nuclei and in vitro and in vivo development of somatic cell nucleus transfer (SCNT) embryos in pigs (Sus scrofa). Somatic cell nucleus transfer oocytes were either untreated (control) or treated with nocodazole or demecolcine after electric activation, then cultured in vitro or transferred to surrogate pigs. Treatment with nocodazole (30%) and demecolcine (29%) after electric activation improved embryo development to the blastocyst stage compared with the control (16%). The rate of oocytes that formed single clusters of chromosomes or a pronucleus 4h after activation was higher after treatment with nocodazole (82%) and demecolcine (86%) than under the control conditions (66%), and this tendency was not altered even 12h after activation. Pseudo-polar body extrusion was inhibited by nocodazole and demecolcine, and the rate of embryos with diploid chromosomes was higher after treatment with nocodazole (86%) and demecolcine (77%) than under control conditions (58%). Nocodazole treatment resulted in a farrowing rate of 50% with a 1.7% efficiency of piglet production, whereas controls showed a farrowing rate of 60% and a production efficiency of 3.8%. Our results demonstrate that postactivation treatment with nocodazole maintains normal nuclear ploidy of cloned embryos likely by increasing nuclear retention and formation of single pronuclei. In vivo development could be achieved from the transfer of nocodazole-treated embryos but showed some defects compared with control.
机译:这项研究的目的是研究诺考达唑激活后的处理对供体核形态变化以及猪体细胞核转移(SCNT)胚胎体外和体内发育的影响(Sus scrofa)。电激活后,未经处理(对照)或用诺考达唑或地美可星处理体细胞核转移卵母细胞,然后在体外培养或转移至代用猪。与对照组(16%)相比,在电激活后用诺考达唑(30%)和地美可辛(29%)进行治疗可将胚胎发育到胚泡期。诺考达唑(82%)和地美考辛(86%)处理后,活化后4h形成单个染色体簇或原核的卵母细胞比率高于对照组(66%),即使在12h内这种趋势也没有改变激活后。诺考达唑和地美colcine抑制了伪极体的挤压,并且在接受诺考达唑(86%)和地美考辛(77%)处理后,具有二倍体染色体的胚胎的发生率高于对照条件下(58%)。诺考达唑处理的产仔率为50%,仔猪生产效率为1.7%,而对照组的产仔率为60%,生产效率为3.8%。我们的结果表明,用诺考达唑进行的激活后处理可保持克隆胚胎的正常核倍性,可能是通过增加核保留和单个前核的形成来实现的。诺考达唑处理的胚胎的转移可实现体内发育,但与对照相比显示出一些缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号